| | | | | |
AGIO Agios Pharmaceuticals, Inc. | €24,3726 | +2,46% | €1,50B | €25,40K | |
SGRY Surgery Partners, Inc. Common Stock | €11,9070 | +2,55% | €1,50B | €47,01K | |
GAB The Gabelli Equity Trust Inc. | €4,8255 | +0,09% | €1,50B | €209,01K | |
HURN Huron Consulting Group Inc. | €93,8508 | +4,20% | €1,49B | €5,64K | |
ENVX Enovix Corporation Common Stock | €6,9706 | -1,45% | €1,49B | €1,18M | |
PAYO Payoneer Global Inc. Common Stock | €4,5067 | +3,03% | €1,49B | €185,63K | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | €12,8274 | +0,11% | €1,49B | €24,27K | |
STGW Stagwell Inc. Class A Common Stock | €5,7932 | +2,29% | €1,49B | €35,96K | |
CASH Pathward Financial, Inc. Common Stock | €68,7735 | +2,94% | €1,49B | €6,70K | |
SNDX Syndax Pharmaceuticals, Inc. | €15,3128 | -2,85% | €1,49B | €2,24M | |
STRA Strategic Education, Inc. Common Stock | €69,2376 | +1,92% | €1,49B | €4,52K | |
CAPR Capricor Therapeutics Inc | €24,2093 | +1,92% | €1,49B | €61,24K | |
AAPG Ascentage Pharma Group International American Depository Shares | €15,8637 | +3,30% | €1,48B | €1,34K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | €7,2611 | +3,16% | €1,48B | €660,68K | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | €23,5931 | +9,86% | €1,48B | €34,53K | |
